Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. - Wikidata - awgldk - TriplyDB

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

http://www.wikidata.org/entity/Q35187343

about

An integrated psychological strategy for advanced colorectal cancer patients Sequential versus combination chemotherapy for advanced colorectal cancer Chronomodulated chemotherapy versus conventional chemotherapy for Advanced and /or Metastatic Colorectal Cancer Selective internal radiation therapy for liver metastases from colorectal cancer Second-line chemotherapy in advanced and metastatic CRC Anti-angiogenic therapies for metastatic colorectal cancer Anti-angiogenic therapy for metastatic colorectal cancer Supportive care for patients with gastrointestinal cancer Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer.Personalized treatment for advanced colorectal cancer: KRAS and beyond Role of surgery in colorectal cancer liver metastases FOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapy Evaluating predictive pharmacogenetic signatures of adverse events in colorectal cancer patients treated with fluoropyrimidines Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer.Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.Practice parameters for the management of colonic cancer II: other issues. Recommendations of the Colorectal Surgical Society of Australia.Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis Survival benefit in patients after palliative resection vs non-resection colon cancer surgery.Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group Review article: non-systemic chemotherapy in the treatment of colorectal cancer-portal vein, hepatic arterial and intraperitoneal approaches.Quality of life and chronotherapy.New treatments with curative intent for metastatic colorectal liver cancer.Characterizing medical care by disease phase in metastatic colorectal cancer.Palliative treatment of patients with colorectal cancer.Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy Metastatic colorectal cancer: systemic treatment in the new millennium.Campto effective and flexible chemotherapy for advanced colorectal cancer.Emerging drugs in colorectal cancer.KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practice Multivariate Analysis of the Survival Rate for Treatment Modalities in Incurable Stage IV Colorectal Cancer Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer.Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer: A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials.Tegafur-uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle.Palliative oxaliplatin-based chemotherapy after exposure to oxaliplatin in the adjuvant setting for colon cancer The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer.Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.

P2860

Q21245616-FA021C32-92EE-44FB-8A63-131726B2908A Q24234461-62470DB6-7877-45B0-8985-07C074DD1661 Q24239845-20000AD5-9A2E-4C95-A997-198E3A0D97DF Q24240448-BC5DE3F0-B536-46F9-98A7-22AA3F4C94FA Q24241235-204FAB78-1EA7-4EEB-AA22-396C00385EFB Q24241813-B23CA716-DA45-46E2-A621-D89CD55DC47D Q24243297-52BE800A-4D90-456A-8562-1CBE9E91647C Q24246675-3A86AF36-4D4D-492B-89EA-DF45187AEAB7 Q24795784-F68BA1D1-C16C-4748-ADA1-5BF10FDBE9C6 Q25256709-FBCCDBA7-9EA8-4395-ACA3-C3AB3163979D Q26822817-718A0BB1-EF02-47CF-B891-B8C8B612A793 Q26830444-588EA57A-7C4E-4109-B856-99F7C0C70782 Q26851060-F91F39FC-3B60-429F-96F0-DCD9878191A9 Q28534572-0AE2D61D-F2FB-49CF-B5FE-3BBF34FB345A Q33330997-B3BC44C3-F76E-463F-9155-21A775BE15A3 Q33403227-A7713755-B386-4467-A5B3-8F3D8185ABE6 Q33414068-D99A68CD-D6F1-4B5F-B0A9-1620569F5153 Q33522017-1B43F387-4646-473F-A36F-D5E639296899 Q33708807-EA45EB5C-A28F-4FF7-AF10-885F07CC1849 Q33844625-F9990BCC-5841-47CD-970D-14F758C8805D Q33914190-646062A5-E4A2-44A3-A4AB-18519233210A Q34017741-0F15C627-57B4-48D6-A89C-96472305FA01 Q34021183-B22128C3-30E1-46B7-B80F-F73318B63D9E Q34374142-5C82B423-F29F-42C4-BFB2-954783672A77 Q34606508-74FC9922-F863-483B-A264-6F944BCE85AB Q34768529-D863BF4F-C469-4D39-A478-E40585B75CF7 Q34974153-275EBEF5-5387-4D1A-9B0F-29D535B7CB65 Q35111182-7AF728FB-ECE2-4545-97F2-A003383FC423 Q35141276-E770EDBF-F95A-408A-89F3-0DFA2CE7BD0E Q35148795-6F37AB0A-CD2A-45D2-A111-288AC938087A Q35200537-D9206B31-4740-43B7-BA68-147D7E261FE2 Q35581170-91E2A221-ACF9-470B-BD17-2DFB13E4179F Q35584667-53B76993-5CA6-410A-A6B4-ACFFB538B880 Q35813089-F508FEC7-3AB1-4AF0-BD9D-51CF53D54827 Q35819857-D8BB7AB9-EC98-4684-97AE-1B6690114648 Q36010326-5F0C0104-9785-4AF1-AD7E-64B128E82A9F Q36061168-2B00A36E-6455-4DBB-ACB5-52F5970750BB Q36062629-EA661969-F7CF-4333-8E47-0681A12C6DA0 Q36079539-124E1E3C-8900-4419-9D5D-8F6A670C0C9F Q36079839-B30C28F4-5CA5-4B09-AE1B-D5FCC4A61A6F

P2860

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

http://www.wikidata.org/entity/Q35187343

description

1993 nî lūn-bûn

@nan

1993 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1993 թվականի մարտին հրատարակված գիտական հոդված

@hy

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

name

Randomised comparison of combi ...... metastatic colorectal cancer.

@ast

Randomised comparison of combi ...... metastatic colorectal cancer.

@en

type

label

Randomised comparison of combi ...... metastatic colorectal cancer.

@ast

Randomised comparison of combi ...... metastatic colorectal cancer.

@en

prefLabel

Randomised comparison of combi ...... metastatic colorectal cancer.

@ast

Randomised comparison of combi ...... metastatic colorectal cancer.

@en

P1433

Q35187343-FF95D34B-23EF-465A-8DAE-0673C580AAF1

P1476

Q35187343-34151129-D770-405D-BE07-A96722317469

P2093

Q35187343-032821C2-850F-4A12-8F5C-977A63C99DA7

Q35187343-352C4D07-380C-44F2-8637-AB71DBF2A157

Q35187343-6A17C73B-38EA-4325-BC7C-D4A3497CB95F

Q35187343-88CD30A9-7072-4D41-8408-372C37BF5B76

Q35187343-FAD6155F-1538-45E3-90AD-9565E8C89C36

P2860

Q35187343-3ABE841A-2B16-409E-B167-F7AF077EA5B7

Q35187343-68899991-2184-43BD-BAEA-44B7DE65CB53

Q35187343-BE546D14-9840-439F-B979-8171C2DA61F4

Q35187343-BF56DACF-980F-43AB-820F-0092B971A471

Q35187343-CC8FEC98-85E6-42F1-ACEC-0BDAFE49A9C6

Q35187343-D90CEB5C-63ED-47D9-A52A-52B6A2D90667

Q35187343-E63926EA-8BD6-4AAE-87AA-984EAFA87988

Q35187343-F0FA4CE7-BC23-4C45-9E23-318EB73CACD1

P304

Q35187343-28C02975-1ED3-4D5F-8C3D-8BBC3CDB2267

P31

Q35187343-4DB357A8-E4BB-4EAA-BCCA-76F248D4EC60

P356

Q35187343-CBF8475D-9E00-4461-AF2D-E74D60CBD8D0

P407

Q35187343-89CD428F-7D64-484C-80ED-7F8D402E01FF

P433

Q35187343-711CD88F-ED34-4AA3-8C70-AE4B2E0AF841

P478

Q35187343-4D8D41E5-BC72-4646-B18A-B610F5DC08DA

P577

Q35187343-59C0F3A7-5B4B-4965-9444-13E3858E1051

P5875

Q35187343-2F4EB3C4-3C02-4D8D-A014-08FD0B570F82

P698

Q35187343-5778C148-8321-49E8-9BC4-592B220A175B

P921

Q35187343-47C565EE-5014-446E-A5EA-135921488246

Q35187343-B659E1CF-19B7-471F-9B94-625DF7CF27F8

P932

Q35187343-B0201A21-521D-4555-BC21-D531BE6F139B

P356

BMJ.306.6880.752

P1433

P1476

Randomised comparison of combi ...... metastatic colorectal cancer.

@en

P2093

Depisch D

http://www.w3.org/2001/XMLSchema#string

Kornek GV

http://www.w3.org/2001/XMLSchema#string

Rosen H

http://www.w3.org/2001/XMLSchema#string

Scheithauer W

http://www.w3.org/2001/XMLSchema#string

Sebesta C

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

Reporting results of cancer treatment

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer.

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.

Proposed criteria for serial evaluation of quality of life in cancer patients.

P304

752-755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.306.6880.752

http://www.w3.org/2001/XMLSchema#string

P407

P433

6880

http://www.w3.org/2001/XMLSchema#string

P478

306

http://www.w3.org/2001/XMLSchema#string

P577

1993-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15515107

http://www.w3.org/2001/XMLSchema#string

P698

7683942

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

1677246

http://www.w3.org/2001/XMLSchema#string